There are many unproven methods of ventilation and oxygenation that have been used in children dying from respiratory failure, including extracorporeal devices and high frequency ventilation. However, no objective predictors of death have been developed that enable clinicians to decide when it is reasonable to use these therapies in children over one month of age with acute respiratory failure. To determine predictors of death, we evaluated the charts of all 42 children aged one month to eighteen years admitted to the intensive care unit who were ventilated for more than twelve hours, received greater than 90% oxygen, received a peak inspiratory pressure greater than 25 cmH20 and had no pre-existing neurodevelopmental handicap. A combination of a variable reflecting ventilation and a variable reflecting oxygenation reliably predicted death: a combination of ventilation index> 40 and oxygenation index > 0.4 was associated with a 77% chance of mortality (sensitivity 65% and specijicity 74%); a combination of peak inspiratory pressure > 40 cmH 2 0 and A-aD0 2 > 580 was associated with an 81% chance of mortality (sensitivity 74% and specijicity 79%). These criteria may be useful in predicting death from respiratory failure in children.
There are many unproven methods of ventilation and oxygenation that have been used in children dying from respiratory failure: these include extracorporeal devices such as extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal (ECCOR), and high frequency ventilation (HFV) techniques such as high frequency oscillation (HFO) and high frequency jet ventilation (HFJV). Although conventional ventilation has not been demonstrated to be of benefit in a controlled trial, it is the standard therapy to which new techniques have to be compared. Although predictors of mortality have been developed for neonates with respiratory failure,I,2 no predictors of death have been developed for use in children over one month of age. These are needed so that clinicians can determine objectively when it is reasonable to consider using new therapies in children.
The survival of newborn infants with severe cardiorespiratory failure appears to have improved with the use of ECMO. For example the mortality from severe persistent foetal circulation has decreased from 40% to 10%, and the mortality from diaphragmatic hernia has decreased from 45% to 25%.3,4 However, before ECMO could be used in neonates, objective selection criteria (that is, predictors of death) were needed. Several studies in newborns established individual hospital selection criteria for ECMO. These included partial pressure of arterial oxygen (P a o 2 ) < 45, alveolar-arterial oxygen gradient (A-aD0 2 ) > 610, and oxygenation index (01) > 0.4. These criteria were associated with an 80% chance of death in the hospitals where the studies were performed. 1 ,2 At present, in children with acute respiratory failure, there are no reliable predictors of death. This retrospective study was undertaken to provide this information.
MATERIALS AND METHODS
Between January 1, 1985, and November 30, 1988, a total of 5637 patients were admitted to the Intensive Care Unit at the Royal Children's Hospital in Melbourne. The charts of all children older than one month were reviewed if they had been ventilated for more than twelve hours, had an inspired fraction of oxygen (FI02) greater than 0.9 and a peak inspiratory pressure (PIP) greater than 25 cmH20, and had no pre-existing neurodevelopmental handicap. Children who died from neurological sequelae after a hypoxic-ischaemic or septic insult were excluded.
Details about the child's illness, diagnosis, mechanical ventilation, oxygenation, inotropic support and survival were recorded. Acute respiratory distress syndrome (ARDS) was defined clinically as a syndrome of low lung compliance, hypoxaemia, and diffuse alveolar and interstitial lung disease radiologically, following an event known to be associated with ARDS and in the absence of heart failure. s The lowest P a o 2 , highest A-aD0 2 , highest oxygenation index (01) and highest ventilation index (VI) for a consecutive four hour period were recorded. 01 was defined as MAP x F102/Pa02, VI was defined as RR x PaC02 x PIP/lOOO, and A-aD02 as F102 x [barometric pressure -PvH 2 0 -[Paco2/0.8]) -P a o 2 ; where MAP represents mean airway pressure, PaC02 represents partial pressure of carbon dioxide, PVH20 represents partial pressure of water vapour and RR represents respiratory rate. MAP was calculated from PIP, PEEP, inspiratory and expiratory times and assuming a square wave pattern of ventilation. Mortality rate, sensitivity and specificity were calculated for each of these variables and for various combinations of variables. Sensitivity was defined as the number of non-survivors in whom the predictor of mortality was positive divided by all the non-survivors, and specificity as the number of survivors in whom the predictor of mortality was negative divided by all the survivors. Positive predictive power was defined as the probability that a patient would die, given that the predictor of mortality was positive. Negative predictive power was defined as the probability that a patient would live, given that the predictor or mortality was negative. 6 The comparison ofventilatory settings and P a o 2 and PaC02 between survivors and nonsurvivors on admission and their worst period was analysed using the Mann-Whitney U Test. The receiver operating curve for each of the clinical predictors was constructed by plotting sensitivity against specificity: 7 for each clinical predictor, the plot nearest to the upper left hand corner of the graph shows the value ofthe predictor that gives optimum sensitivity and specificity (assuming that equal weight is given to true positive and true negative results).
RESULTS
There were 42 patients who satisfied the entry criteria: the median age was 2.95 years (range one month to eighteen years) and the median weight was 14.0 kg (range 2.3 to 60 kg). The diagnoses were adult respiratory distress syndrome (23 patients, 13 died), pneumonia (13 patients, 7 died), asthma (3 patients, 2 died), bronchiolitis (2 patients, 0 died) and pulmonary haemorrhage (1 patient, 1 died). No child had structural heart disease. Twenty-three children died and nineteen survived: ten of the survivors were normal, five had mild handicap and four had moderate handicap. The cause of death in all cases was progressive cardiorespiratory failure with or without multiple organ failure. There was no significant difference between survivors and non-survivors at the time of admission with respect to ventilator settings and arterial blood gases ( Table  1 ). The worst ventilator settings, arterial blood gases, A-aD02, 01 and VI were similar in each group (Table 2) . Table 3 shows the highest mortality rate and respective sensitivity and specificity for each of the potential predictors of death, both alone and in various combinations. The individual criteria alone had poor sensitivity and specificity, with a mortality rate of only 50-60%. However, when one of the criteria that reflected ventilation was combined with one that reflected oxygenation, the mortality prediction rate was 75-80%, the *Mann-Whitney U Test sensitivity and specificity were 74-79%, and the positive predictive power was 75-81 % and the negative predictive power was 64-71 %. These differences were statistically significant for VI > 40 and 01> 0.4 (P= 0.026), PIP> 40 cmH 2 0 and A-aD0 2 > 580 (P= 0.001), and PIP> 40 cmH 2 0 and 01 > 0.3 (P = 0.005). A receiver operating curve for each combination is shown in Figure 1 . The point on the curve nearest to the top left hand corner of the graph was selected as the value for that variable that best predicted mortality.
DISCUSSION
With increasing use of unproven techniques such as ECMO, ECCOR, HFO and HFJV in acute respiratory failure in children who are thought to be dying, it is essential to establish reliable objective predictors of death. It is likely that some or all of the unconventional therapies will prove to be no better than standard therapy, and some may be worse.
ECMO has been used in clinical practice since the early 1970s_ 8, 9 In the newborn child it is clear that ECMO improves survival,3,1O,11 but in the few older children treated with ECMO, survival has been only 30-40%. The few studies that have been performed in adults have shown no improvement in survival of patients treated with ECMO.12,13 One of the main differences between the newborn infant and the older child is the diversity and possible irreversibility of conditions that cause respiratory failure in older children. Also, many children and adults with respiratory failure have multiple organ failure, which increases mortality. 14 In children and adults, the average duration of ECMO is ten to fourteen days compared with five days in newborn infants. 1 1,14 This increases the riskof complications such as infection, haemorrhage or equipment failure.
In view of the poorer survival and longer duration of paediatric ECMO, it is highly desirable that a controlled trial ofECMO be performed. Thus it is imperative to establish local selection criteria for ECMO in children. As with ECMO in neonates, a 75-80% chance of death would seem a reasonable time to consider using ECMO in children. When we combined an A-aD0 2 > 580 with a peak inspiratory pressure> 40 cmH20, there was an 81 % mortality rate with a sensitivity of 74% and a specificity of 79%. This was the best statistical predictor of death in our study. Other combinations that were statistically significant were VI > 40 with 01 > 0.4 (P = 0.026), and PIP> 40 cmH 2 0 with 01 > 0.3 (P= 0~005). In practice, the sensitivity of these clinical predictors is better than shown here because only very ill, ventilated children were included in this study. The sensitivity would have improved considerably if all ventilated children had been evaluated. The choice of which predictor to use is difficult, but we favour the VI plus 01 combination because PC02 is determined by minute ventilation (VI consists of PaC02 multiplied by an index of minute ventilation) and P0 2 is determined by MAP and F I 0 2 (01 consists of MAP multiplied by FI02 and divided by P a02)' Use of PIP alone as a predictor of mortality is likely to be less accurate than using VI (a patient being ventilated with a PIP of 42 cmH 2 0 with a PaC02 of 30 is possibly less likely to die than a patient with a PIP of 38 cm H20 and a PaC02 of 60 mmHg). Similarly, use of A-aD0 2 alone as a predictor of mortality is likely to be less accurate than using 01 (a patient who needs an MAP of 15 to achieve a given A-aD0 2 is less likely to die than one who needs an MAP of 30 to achieve the same A-aD0 2 ). The difference between the three different combinations of variables as predictors of mortality was not statistically significant. The presence of VI > 40 and 01 > 0.4 is associated with an 80% mortality rate, and we feel that it may be a reasonable indication for the use of an unproven therapy such as ECMO. However, a prospective study would be required to establish the true predictive power of VI > 40 and 01 > 0.4 in our unit. Individual selection criteria should be determined by each centre involved in paediatric ECMO; this would allow for comparison of results, and perhaps a multi centre controlled trial.
